Multimodal Stepped Care Approach Involving Topical Analgesics for Severe Intractable Neuropathic Pain in CRPS Type 1: A Case Report

A multimodal stepped care approach has been successfully applied to a patient with complex regional pain syndrome type 1 and severe intractable pain, not responding to regular neuropathic pain medication. The choice to administer drugs in creams was made because of the intolerable adverse effects to oral medication. With this method, peak-dose adverse effects did not occur. The multimodal stepped care approach resulted in considerable and clinically relevant decrease in pain after every step, using topical amitriptyline, ketamine, and dimethylsulphoxide.

[1]  D. J. Kopsky,et al.  High Doses of Topical Amitriptyline in Neuropathic Pain: Two Cases and Literature Review , 2012, Pain practice : the official journal of World Institute of Pain.

[2]  S. Bruehl,et al.  An Update on the Pathophysiology of Complex Regional Pain Syndrome , 2010, Anesthesiology.

[3]  C. Maihöfner,et al.  Complex regional pain syndromes: new pathophysiological concepts and therapies , 2010, European journal of neurology.

[4]  P. Dijkstra,et al.  Evidence based guidelines for complex regional pain syndrome type 1 , 2010, BMC neurology.

[5]  D. J. Kopsky,et al.  A new combination cream for the treatment of severe neuropathic pain. , 2010, Journal of pain and symptom management.

[6]  L. Knudsen,et al.  Reduction of allodynia in patients with complex regional pain syndrome: A double-blind placebo-controlled trial of topical ketamine , 2009, PAIN.

[7]  J. Marinus,et al.  Ketamine produces effective and long-term pain relief in patients with Complex Regional Pain Syndrome Type 1 , 2009, PAIN.

[8]  J. Dieleman,et al.  Outcome of the Complex Regional Pain Syndrome , 2009, The Clinical journal of pain.

[9]  E. Hsu.  Practical Management of Complex Regional Pain Syndrome , 2009, American journal of therapeutics.

[10]  A. Moghadamnia,et al.  Evaluation of the effect of locally administered amitriptyline gel as adjunct to local anesthetics in irreversible pulpitis pain. , 2009, Indian journal of dental research : official publication of Indian Society for Dental Research.

[11]  R. Schwartzman,et al.  Efficacy of ketamine in anesthetic dosage for the treatment of refractory complex regional pain syndrome: an open-label phase II study. , 2008, Pain medicine.

[12]  Lawrence A Leiter,et al.  The 2007 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy. , 2007, The Canadian journal of cardiology.

[13]  P. Wiffen,et al.  Antidepressants for neuropathic pain. , 2007, The Cochrane database of systematic reviews.

[14]  Jamshed Anwar,et al.  Modulating the structure and properties of cell membranes: the molecular mechanism of action of dimethyl sulfoxide. , 2007, The journal of physical chemistry. B.

[15]  J. Dieleman,et al.  The incidence of complex regional pain syndrome: A population-based study , 2007, Pain.

[16]  J. M. Wallace,et al.  Update on pharmacotherapy guidelines for treatment of neuropathic pain , 2006, Current pain and headache reports.

[17]  M. Swan,et al.  Treatment of complex regional pain syndrome: functional restoration. , 2006, The Clinical journal of pain.

[18]  C. Argoff,et al.  Rational multidrug therapy in the treatment of neuropathic pain , 2006, Current pain and headache reports.

[19]  R. Gallagher.  Management of Neuropathic Pain: Translating Mechanistic Advances and Evidence-based Research Into Clinical Practice , 2006, The Clinical journal of pain.

[20]  M. Sullivan,et al.  Topical amitriptyline and ketamine in neuropathic pain syndromes: an open-label study. , 2005, The journal of pain : official journal of the American Pain Society.

[21]  J. Sawynok.  Topical analgesics in neuropathic pain. , 2005, Current pharmaceutical design.

[22]  R. Schwartzman,et al.  Multi-day low dose ketamine infusion for the treatment of complex regional pain syndrome. , 2005, Pain physician.

[23]  Edward J Gracely,et al.  Subanesthetic ketamine infusion therapy: a retrospective analysis of a novel therapeutic approach to complex regional pain syndrome. , 2004, Pain medicine.

[24]  J. Bernstein,et al.  Topical analgesics: A new topical medication for the adjunctive relief of painful diabetic neuropathy and postherpetic neuralgia , 2004 .

[25]  E. Lockhart.  D. Treatment approaches (medical/interventional)Topical analgesics: Topical combination of amitriptyline and ketamine for post herpetic neuralgia , 2004 .

[26]  R. McClelland,et al.  Complex regional pain syndrome type I: incidence and prevalence in Olmsted county, a population-based study , 2003, PAIN®.

[27]  C. Jenkins,et al.  Impact of Inhaled Salmeterol/Fluticasone Propionate Combination Product versus Budesonide on the Health-Related Quality of Life of Patients with Asthma , 2002, American journal of respiratory medicine : drugs, devices, and other interventions.

[28]  T. Ushida,et al.  Analgesic Effects of Ketamine Ointment in Patients With Complex Regional Pain Syndrome Type 1 , 2002, Regional Anesthesia & Pain Medicine.

[29]  R. Coggeshall,et al.  Inflammation-induced changes in peripheral glutamate receptor populations , 1999, Brain Research.

[30]  K. Dickersin,et al.  Single agent versus combination chemotherapy in patients with advanced nonsmall cell lung carcinoma , 1998, Cancer.

[31]  R. Coggeshall,et al.  Receptor localization in the mammalian dorsal horn and primary afferent neurons , 1997, Brain Research Reviews.

[32]  J. Lange,et al.  Treatment of acute reflex sympathetic dystrophy with DMSO 50% in a fatty cream , 1996, Acta anaesthesiologica Scandinavica.

[33]  J. Arendzen,et al.  Reflex sympathetic dystrophy: early treatment and psychological aspects. , 1994, Archives of physical medicine and rehabilitation.

[34]  R. Goris,et al.  Are toxic oxygen radicals involved in the pathogenesis of reflex sympathetic dystrophy? , 1987, Free radical research communications.